Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S7VN
|
||||
Former ID |
DIB009253
|
||||
Drug Name |
MRL-953
|
||||
Synonyms |
SDZ-MRL-953
|
||||
Indication | Immune disorder [ICD10:D80-D89] | Terminated | [545071] | ||
Company |
Novartis AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)OC(=O)C[C@H](O)C<br />CCCCCCCCCC)OC(=O)C[C@H](O)CCCCCCCCCCC)NC(=O)C[C@H](O)CC<br />CCCCCCCCC)OP(=O)(O)O
|
||||
CAS Number |
CAS 123136-61-8
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-1 receptor, type II | Target Info | Agonist | [534068] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
Pathway Interaction Database | IL1-mediated signaling events | ||||
Reactome | Interleukin-1 signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.